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Abstract
Background: Objective of the study was to evaluate the diagnostic value of novel ultrasonographic modalities in
comparison with simultaneously performed liver biopsy.
Methods: The results of simultaneously performed examinations using Acoustic Structure Quantification (ASQ),
Virtual Touch Imaging and Quantification (VTIQ) and Virtual Touch Tissue Quantification (VTTQ) were compared
with the findings of liver biopsy in patients with a wide variety of diffuse hepatopathies (n = 51). The histologically
determined fibrosis stage according to Desmet and Scheuer was compared with quantitative measurements
returned by the ultrasonographic imaging modalities.
Results: No statistically significant correlation with histologically determined fibrosis stage could be identified for
any measurements returned using ASQ. Increasing severity of hepatic steatosis, however, was associated with a
reduction in the focal disturbance (FD) ratio (r = −0.55; p < 0.0001). The shearwave velocities measured using VTTQ
satisfyingly correlated with fibrosis stage (r = 0.56; p > 0.0001). Fibrosis stages > F2 were associated with an area under
the curve (AUC) of 0.94 (95 %-CI:0.84–0.99). A cut-off value for shearwave velocity of 1.66 m/s was determined with a
sensitivity of 100 % and a specificity of 84 %. VTIQ showed a less pronounced but acceptable correlation with fibrosis
stage (r = 0.35; p = 0.0154). For fibrosis stages > F2 analysis showed an AUC of 0.84 (95 %-CI:0.70–0.93). The cut-off value
was 1.82 m/s with a sensitivity of 100 % and a specificity of 58 %.
Conclusion: While ASQ showed no diagnostic advantage in our patient collective, VTTQ showed high reliability for
determining severe liver fibrosis in a group of patients with diffuse liver diseases of different etiology.
Keywords: Acoustic Structure Quantification (ASQ), Acoustic Radiation Force Impulse (ARFI), Elastography,
Liver fibrosis, Virtual touch
Background
The diagnosis and follow-up monitoring of diffuse hepa-
topathies continues to present modern Medicine with a
number of challenges. In many cases, an exact determin-
ation of the disease entity at hand requires liver biopsy
and remains the gold standard for the diagnosis of
diffuse hepatopathies. Histological assessment, however,
is crucial not only for confirming the initial diagnosis
but remains important for therapeutic management and
subsequent monitoring of patients’ progress. For ex-
ample, the fibrosis stage is one of the most important
markers in hepatitis C virus (HCV) infection [1]: the
success rate for antiviral therapy depends on the fibrosis
stage at time of initiation of therapy [2]. Patients with
fibrosis stage 3 disease should in addition be regularly
screened for hepatocellular carcinoma (HCC) [3]. The
miniscule volume of the liver biopsy cylinder represents
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only 1/50,000 of the total mass of the liver, which under-
scores the possibility of misinterpretations in the sense
of a sampling error [4]; the reliability of the assessment
increases in proportion to the length of the tissue cylin-
der [5]. Multiple tissue samples or the use of longer punc-
ture needles may help to maximize length, though the
latter is associated with an increased risk of bleeding [6].
The need for alternatives brought up a variety of new tech-
nologies, like transient elastography, magnetic resonance
elastography or later shearwave elastography. Quantifying
the stiffness of the liver, would allow to draw conclusions
about the extent of liver fibrosis. Both transient elastogra-
phy and Acoustic Radiation Force Impulse (ARFI) shear-
wave elastography represent ultrasonographic methods
that permit quantitative assessment of liver elasticity.
Numerous studies have described a nearly equivalent sen-
sitivity for these two methods in detecting liver fibrosis
stages ≤ F2 [7]. Even though transient elastography has
been available for a longer period, the need for a devise
only dedicated to this examination, restricts clinical prac-
ticability. Magnetic response elastography is however ex-
pensive in time and limited in its availability. As opposed
to this shearwave elastography is integrated in a conven-
tional ultrasonic devise. Another approach to determine
liver fibrosis non-invasive was the detection of structural
alterations of the liver parenchyma. Acoustic Structure
Quantification (ASQ) is a novel modality developed by
Toshiba that permits analysis of tissue homogeneity in the
liver [8, 9] whose diagnostic value has been discussed in
only a few publications to date. Objective of the present
study was to evaluate the diagnostic value of ASQ and
ARFI in comparison to liver histology in patients with dif-
fuse liver diseases of different etiology.
Methods
Study design
A collective of 51 patients with diffuse hepatopathies sched-
uled to undergo diagnostic liver biopsy were examined by
means of elastography and ASQ in the present prospective
clinical study. Prior to recruiting patients, the study proto-
col was approved by the University’s ethics commission ac-
cording to the Helsinki Declaration. Each patient provided
his or her informed written consent to participation in the
study. Ultrasonographic examinations were performed on
the same day and several hours prior to the planned liver
puncture. The examiner was blind to the fibrosis score of
the patient, as the pathologist was blind to the ultrasonic
measurements. All ultrasonic examinations were performed
by a single person. This study was performed without any
financial support or other consideration.
Liver biopsy and histology
Tissue samples were obtained either laparoscopically or
under ultrasonographic guidance. Due to accessability,
the right hepatic lobe was the source of biopsy materal
in most cases. Liver fibrosis was assessed by the hospi-
tal’s department of pathology according to Desmet und
Scheuer [10] and assigned to one of five stages, ranging
from stage F0 (no fibrosis) to stage F4 (liver cirrhosis).
Tissue samples used for assessment were at least
10 mm in length and contained at least four portal
tracts. Cases diagnosed as intermediate stages were
assigned to the next higher stage. In addition, three
steatosis stages were defined: grade 0 with lipid inclu-
sions in < 5 % of hepatocytes; grade 1, 5–30 %; and
grade 2, >30 %.
Acoustic Structure Quantification (ASQ)
Acoustic Structure Quantification (ASQ) is a novel
feature of the Toshiba Aplio 500 ultrasound system
(6C1 convex transducer head) that is intended to
facilitate analysis of tissue homogeneity in the liver.
This is based on an analysis of the Probability Dens-
ity Function (PDF) in raw imaging data. Yamaguchi
et al. [11, 12] were able to demonstrate experimen-
tally that PDF of echo amplitudes in ideal liver tissue
approximates a Rayleigh distribution. A statistical
analysis allows the program to detect deviations of
the variances of these PDF from the expected Ray-
leigh distribution. Quantitative analysis generates a
chi-square histogram for a defined measurement
area. The higher the chi-square value, the greater the
deviation from ideal tissue. With the version available
to us, macrostructures within the measurement area
were detectable with the help of mathematical loga-
rithms. These are presented in a separate curve and
can be interpreted as small vascular and connective
tissue structures. The relationship between the AUC
of these macrostructures and the AUC of the “paren-
chyma” curve is designated the focal disturbance
(FD) ratio. In the present study, a five-second raw
data clip of the subcostal longitudinal and cross
section was recorded for each patient. Analysis was
performed on a separate computer employing the
PC-ASQR V1.01R000 software. Here, up to four re-
gions of interest (ROI) were defined in B scan in
such a way as to cover the largest area of liver par-
enchyma possible while avoiding large connective tis-
sue or vascular structures. Measurements from five
frames per video clip were compiled. Care was taken
that ROIs were placed only in regions with a visually
qualified good signal-to-noise ratio.
Shear wave elastography
The method used in the present study is a subform of
shear wave elastography belonging to ARFI elastogra-
phy. Measurements were acquired using a conven-
tional ultrasound unit (Siemens Acuson S3000), which,
Keller et al. BMC Medical Imaging  (2015) 15:58 Page 2 of 7
together with the Virtual Touch program, allows for
quantitative determination of tissue elasticity using ei-
ther of two different modalities. Virtual Touch Tissue
Quantification (VTTQ) allows individual B scan mea-
surements while Virtual Touch Tissue Imaging and
Quantification (VTIQ) permits parallel measurements
within a primary ROI of freely determined size using a
linear transducer. Measurements are color coded de-
pending on shear wave velocity. Six intercostal mea-
surements at 5 cm depth in different areas of the right
hepatic lobe were obtained using VTTQ. For VTIQ,
the left hepatic lobe was also examined. Here, via an
epigastric approach, six measurements 15 mm beneath
the liver capsule were acquired while, in the right hep-
atic lobe, six measurements, each, were obtained at
15 mm and 20 mm beneath the liver capsule.
Statistical analysis
Statistical evaluation of the data was performed using
the “Statistiklabor” (v. 3.81, Free University of Berlin,
Germany). All other analyses were performed using the
open source “R” software (v. 3.1.2). Following the com-
pilation of data, the medians of the individual measure-
ments were represented for the respective fibrosis
stage using a boxplot graph and analyzed for statisti-
cally significant differences using the Wilcoxon-
Mann–Whitney-Test. Correlation of the individual
parameters was tested after calculation of the Spear-
man rank correlation coefficient “r”. The level of
significance was set to α = 0.05. Correlation was differ-
entiated in poor (0 < r < 0.3), acceptable (0.3 ≤ r < 0.5),
satisfied (0.5 ≤ r < 0.7), good (0.7 ≤ r < 0.9) and excellent
(r ≥ 0.9). In addition, the Receiver Operating Charac-
teristics (ROC) curves were determined using the
Acomed “ROC Curve” and the Area Under the Curve
(AUC) was calculated.
Results
Tables 1 and 2 presents an overview of the patient col-
lective and other measurement parameters. Because of
the small number of patients diagnosed as being in
fibrosis stage F4, these patients were grouped together
with patients with stage F3 disease. Four of 51 patients
were excluded from the analysis due to missing or in-
complete biopsy findings.
Acoustic Structure Quantification (ASQ)
All measurements were successfully performed. For
the correlation of the longitudinal and cross sec-
tions of the liver, a Spearman correlation coefficient
of r = 0.61 was returned for the modes of the chi-
square histogram (p < 0.001); r = 0.73 for the me-
dians (p < 0.0001) and r = 0.75 for the FD ratios (p <
0.0001). None of these measurement parameters
were found to correlate in any way with the fibrosis
stage, nor did differentiation of the fibrosis stage
based on the measurement parameters using the
Wilcoxon-Mann–Whitney Test yield statistically
significant results. However, for both the longitu-
dinal and cross sections, our findings did show a nega-
tive, satisfied correlation with the degree of hepatic
steatosis for the modes (r = −0.50; p = 0.0003), means
(r = −0.53; p = 0.0001) and the FD ratios (r = −0.60;
p < 0.0001). Considering only those subjects without
hepatic steatosis, our findings similarly fail to support a
statistically significant correlation of ASQ measure-
ments with fibrosis stage. Figure 1 shows the FD-ratios
of the liver cross sections in relation to the correspond-
ing degree of steatosis.
Table 1 Overview of the subject collective and individual
measurement parameters
N (%); mean ± STD
Number of subjects 51
Gender
Male 31 (61 %)
Female 20 (39 %)
Age (years) 51 ± 11
Weight (kg) 75 ± 14
Height (m) 1.7 ± 0.1
BMI (kg/m2) 25.5 ± 3.5
Hepatopathies
Hepatitis C 13 (25 %)
Hepatitis B 5 (10 %)
Non-alcoholic Steatohepatitis (NASH) 10 (20 %)
Non-alcoholic fatty liver disease (NAFLD) 6 (12 %)
Autoimmune Hepatitis (AIH) 5 (10 %)
Toxic liver damage 3 (6 %)
Other and Unknown 9 (17 %)
Fibrosis stage (Desmet/Scheuer)
Stage F0 15 (32 %)
Stage F1 10 (21 %)
Stage F2 13 (28 %)
Stage F3 and F4 9 (19 %)
Tissue cylinder
Length (cm) 1.8 ± 0.6
Portal tracts 7 ± 3
Hepatocytes with lipid inclusions
Grade 0: <5 % 34 (67 %)
Grade 1: 5–30 % 10 (20 %)
Grade 2: >30 % 7 (13 %)
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Table 2 Overview of the measured parameters with VTTQ (Virtual Touch Tissue Quantification), VTIQ (Virtual Touch Tissue Imaging &
Quantification) and ASQ (Acoustic Structure Quantification). Wilcoxon-Mann–Whitney-test was used to differentiate the groups. The
level of significance was set to α = 0.05
Fibrosis stage Mean ± STD Wilcoxon-Mann–Whitney-test against fibrosis stage
F1 F2 F3 and F4
VTTQ righ liver lobe, 5 cm deep Shearwave velocity [m/s]
F0 1.37 ± 0.37 p = 0.698 p = 0.153 p < 0.001
F1 1.37 ± 0.26 - - - p = 0.153 p < 0.001
F2 1.62 ± 0.81 p = 0.153 - - - p = 0.002
F3 and F4 2.61 ± 0.73 p < 0.001 p = 0.002 - - -
VTIQ right liver lobe, 1.5 cm under liver capsule Shearwave velocity [m/s]
F0 1.91 ± 0.44 p = 0.254 p = 0.482 p = 0.022
F1 1.64 ± 0.27 - - - p = 0.710 p = 0.003
F2 1.97 ± 0.39 p = 0.482 - - - p = 0.002
F3 and F4 2.42 ± 0.58 p = 0.003 p = 0.002 - - -
ASQ right liver lobe, longitudinal section Focal Disturbance - Ratio
F0 0.18 ± 0.13 p = 0.764 p = 0.505 p = 0.717
F1 0.19 ± 0.16 - - - p = 0.443 p = 0.386
F2 0.17 ± 0.17 p = 0.443 - - - p = 0.800
F3 and F4 0.17 ± 0.19 p = 0.386 p = 0.800 - - -
Fig. 1 Focal Disturbance (FD) Ratio of liver cross sections grouped according to the respective steatosis grade measured using Acoustic Structure
Quantification (ASQ). Grade 0: < 5 % of hepatocytes with lipid inclusions, Grade 2: 5–30 %, Grade 3: >30 %
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Shearwave elastography
The results of the VTTQ measurements show a satisfied
correlation with r = 0.56 (p < 0.0001) with respect to the
stage of fibrosis. For VTIQ measurements in the right
hepatic lobe, an r values of 0.35 (p = 0.0154) and a poor
correlation with r = 0.25 (p = 0.1094) were achieved for
measurements at 15 mm and 20 mm beneath the
capsule, respectively, while, for the left hepatic lobe, an
r = 0.16 (p = 0.2913) was calculated for measurements at
a depth of 15 mm. A statistically significant difference in
VTTQ measurements was demonstrated using the
Wilcoxon-Mann–Whitney test between patients with
fibrosis stages F3 and F4 compared with all other stages
(p < 0.003). Similar findings were returned for VTIQ
measurement of the right hepatic lobe at 20 mm depth
(p < 0.023) but not in the left hepatic lobe at 15 mm
depth and only for stages F0 and F1 in the right hepatic
lobe at a depth of 15 mm. No statistically significant dif-
ferences could be shown for stages F0 to F2. The AUC
values and cut-off values determined from the ROC
curves are shown in Table 3. Figure 2 presents the corre-
sponding ROC curves for differentiation of the respect-
ive fibrosis stages.
In addition, other factors were assessed for their influ-
ence on shearwave velocities. Ignoring the fibrosis stage,
it was possible to detect an acceptable statistically
significant correlation for bile duct diameter (r = 0.33;
p = 0.0195) and for the degree of inflammation according
to Desmet/Scheuer (r = 0.42; p = 0.0034). Limiting the col-
lective to the lower fibrosis stages (< F2), these correla-
tions were no longer observed and we also found no
significant correlation for other parameters, such as portal
vein diameter or mean portal vein flow. The diameter of
the common bile duct (CBD; r = 0.33; p = 0.0238) and the
degree of inflammation (r = 0.78; p < 0.0001) also corre-
lated acceptably, respectively well with the fibrosis stage
and thus possibly only apparently with the shearwave
velocities. No significant correlation of the measurements
with other parameters could be demonstrated.
Discussion
Acoustic Structure Quantification (ASQ)
To date, only a few studies investigating the relatively
new Acoustic Structure Quantification (ASQ) technique
have been published. The influence of hepatic steatosis
on measurements observed in the present study had
already been reported by Kuroda et al. in leptin-deficient
mice [13]. Those authors postulated that the increasing
number and size of fat droplets overlying microscopic
interferences leads to a homogenization of the ultra-
sound image. Because this correlation was identified in
our data for the medium and high values in the chi-
square histogram, a co-existing hepatic steatosis might
lead to interferences affecting fibrosis detection. Ricci et
al. [8] and Toyoda et al. [9] were able to demonstrate
statistically significant differences for the chi-squared
values of the individual fibrosis stages. Ricci et al. [8]
mention the influence on measurement results caused
by hepatic steatosis but the prevalence within their sub-
ject collective remains unclear. In the study of Toyoda et
al. [9], no cases of severe hepatic steatosis (>30 % of he-
patocytes with lipid inclusions) were observed. If, in the
present study, those patients with hepatic steatosis had
been excluded from the analysis, there would also have
been no statistically significant differences. A current
publication by Krämer et al. [14] similarly found no sta-
tistically significant correlation of ASQ measurement pa-
rameters with fibrosis stage. Here, again, precise data
regarding the prevalence of hepatic steatosis in the study
collective were not reported. In addition, both Krämer et
al. and the other two studies cited above utilized a ver-
sion of the ASQ software that differed from that used in
the present study: whereas Toyoda et al. [9] used a
prototype they had themselves developed, both Ricci et
Table 3 “Area Under the Curve” (AUC) values calculated from a Reciever Operating Characteristics (ROC) curve for differentiation of
the individual fibrosis stages according to Desmet and Scheuer based on measured shear wave velocities
Fibrosis stage
Stage F1 Stage F2 Stage > F2
VTTQ AUC (95 %-CI) 0.55 (0.34–0.75) 0.65 (0.47–0.79) 0.94 (0.84–0.99)
Cut Off (Sensitivity/Specificity) 1.21 m/s (80 %/40 %) 1.36 m/s (77 %/56 %) 1.66 m/s (100 %/84 %)
VTIQ 15 mm depth Left hepatic lobe AUC (95 %-CI) - - 0.82 (0.67–0.92)
Cut Off (Sensitivity/Specificity) - - 1.90 m/s (83 %/65 %)
VTIQ 15 mm depth Right hepatic lobe AUC (95 %-CI) - - 0.84 (0.70–0.93)
Cut Off (Sensitivity/Specificity) - - 1.82 m/s (100 %/58 %)
VTIQ 20 mm depth Right hepatic lobe AUC (95 %-CI) - - 0.87 (0.73–0.95)
Cut Off (Sensitivity/Specificity) - - 1.60 m/s (100 %/62 %)
VTTQ Virtual Touch Tissue Quantification, VTIQ Virtual Touch Tissue Imaging & Quantification, CI Confidence Interval
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al. [8] and Krämer et al. [14] used commercially avail-
able, though older, versions of the ASQ software. It is
impossible to estimate to what extent the results of the
respective studies depend on the respective software ver-
sions. Furthermore, inaccuracies in data collection can-
not be excluded. There are no established uniform
measuring points concerning ASQ analysis until now.
Our approach was to try to cover as much liver paren-
chyma with the ROIs as possible, while avoiding sizeable
vessels. Up to four ROIs can be placed, but because they
are of a fixed form and stretching out in relation to the
fanning out of the ultrasonic picture, accurate placement
of the ROI is aggravated. This led to the use of smaller
ROIs, thus covering a smaller amount of the liver paren-
chyma. Including a small vessel can lead to significant
differences of reran measurements. Since according to
Ricci et al. [8] results the differences in Cm2-values of
the fibrosis stages are small in comparison to the range
of measured values, the slightest variations can de-
generate the diagnostic value. The algorithm discrimin-
ating Rayleigh- and non-Rayleigh-elements, additionally
causes inaccuracies depending on the cut-off value and
therefore compounds data interpretation. Assessment
errors at the histopathological examination are also pos-
sible. With only 51 patients, the subject collective in the
present study is relatively small and no data from a
healthy subject collective were available for comparison.
The results of the present study fail to support a diag-
nostic advantage for ASQ.
Virtual Touch Tissue Imaging & quantification (VTIQ)
Virtual Touch Imaging & Quantification (VTIQ) was
originally designed for the study of superficial structures
and has not yet been widely studied as a method for
assessing the liver. Leschied et al. [15] investigated the
method for evaluating hepatopathies in infants and
found statistically significant increases in shear wave vel-
ocities in cases of congenital bile duct atresia compared
with other hepatopathies. The limitations that were ob-
served in the present study related primarily to the re-
duced penetration depth of the high-frequency linear
transducer head. Although the technical penetration
depth is supposed to be up to 6 cm, depending on the
attenuation of the ultrasound by the subcutaneous fat
tissue we partially experienced difficulties even measur-
ing at a total depth of 4 cm. While our findings did show
VTIQ to be capable of differentiating higher fibroses
stages, the greater duration of the measurement, as com-
pared with VTTQ, makes the modality more susceptible
to measurement artifacts. The limitations of measure-
ment depth may, depending on the patient’s physical
habitus, restrict measurements to the immediate subcap-
sular zone, which may similarly falsify the measure-
ments. VTIQ, therefore, may be of use in assessing the
elasticity of superficial structures and in pediatric cases.
With respect to the diagnosis of diffuse hepatopathies,
VTTQ appears to be the better choice especially in
adults.
Virtual Touch Tissue Quantification (VTTQ)
Shear wave elastography has been extensively re-
searched. Hence, there is already a large literature con-
sisting of published studies and several larger, pooled
meta-analyses [16, 17] regarding ARFI technology’s role
in detecting fibrosis. Nierhoff et al. [17] have confirmed
its high reliability (AUC = 0.89) for differentiation of
fibrosis stages > F2. In their study, the cut-off value for
severe fibrosis stood at 1.61 m/s, which differs only
negligibly from the cut-off value of 1.66 m/s observed in
the present study. An accurate differentiation of fibrosis
stage F1 proved impossible in any of the included
studies. Reasons for the discrepancy of some of the
findings certainly include the quality requirements estab-
lished for the liver biopsy specimens in the respective
studies. The meta-analysis of Bota et al. [16] showed
that, while some studies did not define a minimum
length for the tissue cylinder or a minimum number of
portal tracts, others required a minimum length of 2 cm
with at least 10 evaluable portal tracts. This latter quality
standard could not be maintained for the present study
and had to be loosened in order to obtain a larger num-
ber of cases, however increasing the risk of erroneous
interpretation by the pathologist. Many studies estab-
lished a maximum quotient of the interquartile ratio
(IQR) to the median of 30 % to minimize measurement
errors [3]. In contrast to other studies measuring repeat-
edly at the same location, we decided to use different
measurement locations at comparable depth and went
Fig. 2 Receiver Operating Characteristics (ROC) curve for differentiation
of the individual fibrosis stages according to Desmet and Scheuer
based on the corresponding shear wave velocities. AUC: Area Under the
Curve; 95 %-CI: 95 % Confidence Interval
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without the 30 % limit. In this way we used the possibil-
ity of a widespread examination of the liver to our ad-
vantage and overcome the local limitations of a single
liver biopsy.
For example, in one subject, an IQR/median quotient
of 104 % was calculated. Histopathology findings only
showed minimal fibrosis, while the laparoscopy report
described scattered fibrotic scars as a sign of incipient
fibrosis. Three of a total of six measurement values lay
below 1.57 m/s, while the remaining three were in ex-
cess of 2.42 m/s. This gap would suggest that the high
values were due to the focal tissue scars. A reproducible
measurement variation could thus provide diagnostically
valuable data and can help to evaluate the histological
findings. This has also been proven by another case, in
which a patient with shearwave velocities above 4 m/s
was histologically diagnosed only with moderate fibrosis.
However the laparoscopical findings of this patient
stated an extensive alteration of liver parenchyma com-
patible with liver cirrhosis. This and the possibility of a
follow-up examination emphasize how elastographic
examination can achieve a diagnostic benefit, in particu-
lar if it is combined with the histological findings.
Conclusions
Based on this examination and other studies' findings
the diagnostic value of ASQ still remains doubtful, be-
cause of the mentioned difficulties in data acquisition
and the proven influence of steatosis hepatis. On the
other hand even if shear wave elastography isn't able to
replace primary liver biopsy, combined with it, it can en-
hance clincal validity. Further on its use as an individual
follow-up examination might help to reduce the amount
of necessary restaging biopsies in patients with chronic
liver disease. Regarding VTIQ, it might be better suited
for superficial organs like thyroid gland or lymph nodes.
However its use in pediatric examination should be fur-
ther investigated.
Abbreviation
ASQ: acoustic structure quantification; VTIQ: virtual touch tissue imaging
quantification; VTTQ: virtual touch tissue quantification; AUC: area under the
curve; CI: confidence interval; HCV: Hepatitis C virus; HCC: hepatocellular
carcinoma; ARFI: acoustic radiation force impulse; FD: focal disturbance;
ROI: region of interest; ROC: receiver operating curve; IQR: interquartile range.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
HM, GT, TS and WK were involved in the design and conduct of the study.
JK, TEMK, and SO collected and analyzed the data. JK, TEMK, RAM and WK
were involved in data interpretation and manuscript writing. All authors read
and approved the final version.
Author details
1Department of Internal Medicine I, University Hospital Ulm,
Albert-Einstein-Allee 23, 89081 Ulm, Germany. 2Department of Diagnostic
and Interventional Radiology, University Hospital Ulm, Albert-Einstein-Allee
23, 89081 Ulm, Germany. 3Louis Stokes Cleveland Department of Veterans
Affairs Medical Center, 10601 East Boulevard, Cleveland, OH 44106, USA.
4Universitätsklinikum Ulm, Zentrum für Innere Medizin, Klinik für Innere
Medizin I, Albert-Einstein-Allee 23, D-89081 Ulm, Germany.
Received: 2 July 2015 Accepted: 13 November 2015
References
1. NIH Consensus Statement on Management of Hepatitis C: 2002.
NIH Consens State Sci Statements. 2002;19:1–46
2. Oze T, Hiramatsu N, Yakushijin T, Mochizuki K, Imanaka K, Yamada A, et al.
The efficacy of extended treatment with pegylated interferon plus ribavirin
in patients with HCV genotype 1 and slow virologic response in Japan. J
Gastroenterol. 2011;46:944–52.
3. Gerstenmaier JF, Gibson RN. Ultrasound in chronic liver disease. Insights
Imaging. 2014;5:441–55.
4. Regev A, Berho M, Jeffers LJ, Milikowski C, Molina EG, Pyrsopoulos NT, et al.
Sampling Error and Intraobserver Variation in Liver Biopsy in Patients With
Chronic HCV Infection. Am J Gastroenterol. 2002;97:2614–8.
5. Bedossa P, Dargère D, Paradis V. Sampling Variability of Liver Fibrosis in
Chronic Hepatitis C. Hepatology. 2003;38:1449–57.
6. Mueller M, Kratzer W, Oeztuerk S, Wilhelm M, Mason RA, Mao R, et al.
Percutaneous ultrasonographically guided liver punctures: an analysis of
1961 patients over a period of ten years. BMC Gastroenterol. 2012;12:173.
7. Frulio N, Trillaud H. Ultrasound elastography in liver. Diagn Interv Imaging.
2013;94:515–34.
8. Ricci P, Marigliano C, Cantisani V, Porfiri A, Marcantonio A, Lodise P, et al.
Ultrasound evaluation of liver fibrosis: preliminary experience with acoustic
structure quantification (ASQ) software. Radiol Med. 2013;118:995–1010.
9. Toyoda H, Kumuda T, Kamiyama N, Shiraki K, Takase K, Yamaguchi T, et al.
B-mode ultrasound with algorithm based on statistical analysis of signals:
evaluation of liver fibrosis in patients with chronic hepatitis C. AJR Am J
Roentgenol. 2009;193:1037–43.
10. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification
of Chronic Hepatitis: Diagnosis, Grading and Staging. Hepatology.
1994;19:1513–20.
11. Yamaguchi T, Hachiya H, Kamiyama N, Ikeda K, Moriyasu F. Estimation of
characteristics of echo envelope using RF echo signal from the liver.
Jpn J Appl Phys. 2001;40:3900–4.
12. Yamaguchi T, Hachiya H, Kamiyama N, Moriyasu F. Examination of the
spatial correlation of statistics informaton in the ultrasonic echo from
diseased liver. Jpn J Appl Phys. 2002;41:3585–9.
13. Kuroda H, Kakisaka K, Kamiyama N, Oikawa T, Onodera M, Sawara K, et al.
Non-invasive determination of hepatic steatosis by acoustic structure
quantification from ultrasound echo amplitude. World J Gastroenterol. 2012;
18:3889–95.
14. Krämer C, Jaspers N, Nierhoff D, Kuhr K, Bowe A, Goeser T, et al. Acoustic
Structure Quantification Ultrasound Software Proves Imprecise in Assessing
Liver Fibrosis or Cirrhosis in Parenchymal Liver Diseases. Ultrasound Med
Biol. 2014;40:2811–8.
15. Leschied JR, Dillman JR, Bilhartz J, Heider A, Smith EA, Lopez MJ. Shear
wave elastography helps differentiate biliary atresia from other neonatal/
infantile liver diseases. Pediatr Radiol. 2014;45:366–75.
16. Bota S, Herkner H, Sporea I, Salzl P, Sirli R, Neghina AM, et al. Meta-analysis.
ARFI elastography versus transient elastography for the evaluation of liver
fibrosis. Liver Int. 2013;33:1138–47.
17. Nierhoff J, Chávez Ortiz AA, Herrmann E, Zeuzem S, Friedrich-Rust M. The
efficiency of acoustic radiation force impulse imaging for the staging of
liver fibrosis: a meta-analysis. Eur Radiol. 2013;23:3040–53.
Keller et al. BMC Medical Imaging  (2015) 15:58 Page 7 of 7
